Advocating Worldwide for Ethical Stem Cell Research and Clinical Translation
The ISSCR advocates on behalf of the stem cell research community around the world, giving researchers a voice in crucial policy and regulatory debates. The ISSCR supports all forms of stem cell and pluripotent cell research, performed under rigorous and transparent oversight. We advocate for embryonic, adult, and reprogrammed stem cell research to move forward in parallel to best understand disease and identify new therapies. The ISSCR is opposed to the premature commercialization and marketing of unproven stem cell-interventions and supports global efforts to improve the regulation of stem cell therapies.
The ISSCR promotes rigorous standards for research integrity, patient welfare, respect for research subjects, transparency, and social justice, as outlined in our Guidelines for Stem Cell Research and Clinical Translation.
ISSCR Guidelines
The ISSCR guidelines address the international diversity of cultural, political, legal, and ethical perspectives related to stem cell research and its translation to medicine. All guidelines maintain and underscore widely shared principles in science that call for rigor, oversight, and transparency in all areas of practice.
Positions and Statements
ISSCR advocates on behalf of the stem cell research community around the world, giving researchers a voice in crucial policy and regulatory debates. The society supports all forms of stem cell research, performed under rigorous and transparent oversight, and advocates that embryonic, adult, and reprogrammed stem cell research must move forward in parallel to best understand disease and identify treatment.
Advocacy Day
The ISSCR provides members with an opportunity to advocate for stem cells and educate policymakers and regulators. The Society leads lead an annual stem cell advocacy day to facilitate conversations about the issues impacting the field.
Lawrence Goldstein Science Policy Fellowship
**ISSCR is currently accepting applications.** Gain firsthand policy and regulatory experience by serving as ex-officio members of the Public Policy Committee for three years and engaging in advocacy days and policy discussions that affect the field of stem cell research and regenerative medicine. Pictured to the left: Current Fellows Mohamed Abou-El-Enein, MD, PhD, MSPH Keck School of Medicine, University of Southern California, USA; Zubin Master, PhD, Mayo Clinic, USA; and Kirstin Matthews, PhD, Baker Institute for Public Policy, Rice University, USA.